The Contagion® HIV / AIDS specialty page provides HIV/AIDS-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
Eric S. Daar, MD; Joseph Eron, MD; Ian Frank, MD; Peter L. Salgo, MD; and Paul E. Sax, MD, describe the potential benefits of having a longer-acting formulation available for the treatment of HIV infections.
Eric S. Daar, MD; Joseph Eron, MD; Ian Frank, MD; Peter L. Salgo, MD; and Paul E. Sax, MD, provide insight on the potential role for newer mechanisms of action in HIV treatment, such as ibalizumab and fostemsavir.
In this segment, Eric S. Daar, MD; Joseph Eron, MD; Ian Frank, MD; Peter L. Salgo, MD; and Paul E. Sax, MD, review the current clinical trial evidence regarding maintenance strategies that use less potent HIV treatment regimens.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512